JP2000507596A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2000507596A5 JP2000507596A5 JP1997535610A JP53561097A JP2000507596A5 JP 2000507596 A5 JP2000507596 A5 JP 2000507596A5 JP 1997535610 A JP1997535610 A JP 1997535610A JP 53561097 A JP53561097 A JP 53561097A JP 2000507596 A5 JP2000507596 A5 JP 2000507596A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US62768496A | 1996-04-02 | 1996-04-02 | |
| US08/627,684 | 1996-04-02 | ||
| US66361696A | 1996-06-14 | 1996-06-14 | |
| US08/663,616 | 1996-06-14 | ||
| US67368296A | 1996-06-25 | 1996-06-25 | |
| US08/673,682 | 1996-06-25 | ||
| PCT/US1997/005597 WO1997037005A1 (en) | 1996-04-02 | 1997-04-02 | Method for preventing hiv-1 infection of cd4+ cells |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007220275A Division JP2008069148A (ja) | 1996-04-02 | 2007-08-27 | Ｃｄ４＋細胞のｈｉｖ−１感染を防ぐ方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2000507596A JP2000507596A (ja) | 2000-06-20 |
| JP2000507596A5 true JP2000507596A5 (enExample) | 2004-12-09 |
Family
ID=27417425
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP9535610A Withdrawn JP2000507596A (ja) | 1996-04-02 | 1997-04-02 | Ｃｄ４▲上＋▼細胞のｈｉｖ―１感染を防ぐ方法 |
| JP2007220275A Withdrawn JP2008069148A (ja) | 1996-04-02 | 2007-08-27 | Ｃｄ４＋細胞のｈｉｖ−１感染を防ぐ方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007220275A Withdrawn JP2008069148A (ja) | 1996-04-02 | 2007-08-27 | Ｃｄ４＋細胞のｈｉｖ−１感染を防ぐ方法 |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP0915969A4 (enExample) |
| JP (2) | JP2000507596A (enExample) |
| AU (1) | AU728512B2 (enExample) |
| CA (1) | CA2250829A1 (enExample) |
| WO (1) | WO1997037005A1 (enExample) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6025154A (en) | 1995-06-06 | 2000-02-15 | Human Genome Sciences, Inc. | Polynucleotides encoding human G-protein chemokine receptor HDGNR10 |
| US6743594B1 (en) | 1995-06-06 | 2004-06-01 | Human Genome Sciences, Inc. | Methods of screening using human G-protein chemokine receptor HDGNR10 (CCR5) |
| US7118859B2 (en) | 1996-01-17 | 2006-10-10 | Progenics Pharmaceuticals, Inc. | Methods for inhibiting HIV-1 infection |
| US6107019A (en) * | 1996-06-14 | 2000-08-22 | Progenics Pharmaceuticals, Inc. | Method for preventing HIV-1 infection of CD4+ cells |
| US7858298B1 (en) | 1996-04-01 | 2010-12-28 | Progenics Pharmaceuticals Inc. | Methods of inhibiting human immunodeficiency virus type 1 (HIV-1) infection through the administration of CCR5 chemokine receptor antagonists |
| EP0975749A2 (en) | 1996-05-28 | 2000-02-02 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | Cc chemokine receptor 5, antibodies thereto, transgenic animals |
| ES2270461T3 (es) * | 1996-06-03 | 2007-04-01 | United Biomedical, Inc. | Anticuerpos contra un complejo de cd4 y un dominio receptor de quemoquina, y sus usos contra las infecciones de vih. |
| MXPA00003885A (es) * | 1997-10-22 | 2004-04-23 | Inst Genetics Llc | Quimiocinas con modificiaciones de la terminacion amino. |
| FR2771423A1 (fr) * | 1997-11-21 | 1999-05-28 | Transgene Sa | Vecteurs permettant d'inhiber ou retarder la liaison d'un virus d'immunodeficience et/ou sa penetration dans une cellule cible |
| US6399078B1 (en) | 1998-06-01 | 2002-06-04 | University Of Maryland Biotechnology Institute | Chemokine—glycosaminoglycan complexes and their use in treating or preventing receptor mediated diseases |
| DE60041489D1 (de) * | 1999-07-09 | 2009-03-19 | Gen Probe Inc | Nachweis von hiv-1 durch amplifizierung von nukleinsäuren |
| US6582920B2 (en) | 2000-09-01 | 2003-06-24 | Gen-Probe Incorporated | Amplification of HIV-1 RT sequences for detection of sequences associated with drug-resistance mutations |
| US7138119B2 (en) | 2000-09-15 | 2006-11-21 | Progenics Pharmaceuticals, Inc. | Compositions and methods for inhibition of HIV-1 infection |
| US7175988B2 (en) | 2001-02-09 | 2007-02-13 | Human Genome Sciences, Inc. | Human G-protein Chemokine Receptor (CCR5) HDGNR10 |
| US7060273B2 (en) | 2001-04-06 | 2006-06-13 | Progenics Pharmaceuticals, Inc. | Methods for inhibiting HIV-1 infection |
| US7393934B2 (en) | 2001-12-21 | 2008-07-01 | Human Genome Sciences, Inc. | Human G-protein chemokine receptor (CCR5) HDGNR10 |
| US7122185B2 (en) | 2002-02-22 | 2006-10-17 | Progenics Pharmaceuticals, Inc. | Anti-CCR5 antibody |
| CA2559809A1 (en) | 2004-03-12 | 2005-11-10 | Human Genome Sciences, Inc. | Antibodies against human g-protein chemokine receptor (ccr5) hdgnr10 |
| KR20080035653A (ko) | 2005-07-22 | 2008-04-23 | 프로제닉스 파머슈티컬스, 인코포레이티드 | Ｈｉｖ―１ 감염 환자에서 바이러스 부하를 감소시키는방법 |
| EP2053060A1 (en) * | 2007-10-24 | 2009-04-29 | Protaffin Biotechnologie AG | SDF-1-based glyocosaminoglycan antagonists and methods of using same |
| CA2922428A1 (en) | 2013-08-29 | 2015-03-05 | Temple University Of The Commonwealth System Of Higher Education | Methods and compositions for rna-guided treatment of hiv infection |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5440021A (en) * | 1991-03-29 | 1995-08-08 | Chuntharapai; Anan | Antibodies to human IL-8 type B receptor |
| US5504003A (en) * | 1994-03-08 | 1996-04-02 | Human Genome Sciences, Inc. | Macrophage inflammatory protein-3 and -4 |
| US6265184B1 (en) | 1995-12-20 | 2001-07-24 | Icos Corporation | Polynucleotides encoding chemokine receptor 88C |
| EP0854918A1 (en) * | 1996-01-30 | 1998-07-29 | The National Institutes of Health | Cells expressing both human cd4 and cxcr4 |
| EP0883687B1 (en) | 1996-03-01 | 2004-10-27 | Euroscreen S.A. | C-c ckr-5, cc-chemikines receptor, derivatives thereof and their uses |
| FR2748938B1 (fr) * | 1996-05-22 | 1998-07-31 | Pasteur Institut | Utilisation de molecules antagonistes de chemokines pour leur activite antivirale notamment contre un retrovirus de type vih |
-
1997
- 1997-04-02 EP EP97917856A patent/EP0915969A4/en not_active Ceased
- 1997-04-02 CA CA002250829A patent/CA2250829A1/en not_active Abandoned
- 1997-04-02 JP JP9535610A patent/JP2000507596A/ja not_active Withdrawn
- 1997-04-02 AU AU26074/97A patent/AU728512B2/en not_active Ceased
- 1997-04-02 WO PCT/US1997/005597 patent/WO1997037005A1/en not_active Ceased
-
2007
- 2007-08-27 JP JP2007220275A patent/JP2008069148A/ja not_active Withdrawn